2m 2m 2m 2m 2m 2m 2m
TREVI THERAPEUTI (TRVI)
NASDAQ
$17.99-$0.26 (-1.42%)
Price as of Aug 03, 2026 7:23 AM EDT- $2.6BMarket Cap
- 148.98%1-Year Change
- BiotechnologyIndustry
TREVI THERAPEUTI (TRVI)
$17.99-$0.26 (-1.42%)
TRVI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.25 | ||
Change | -$0.15 (-0.82%) | ||
Open | $18.49 | ||
High | $18.49 | ||
Low | $17.64 | ||
Previous Close | $18.40 | ||
Volume | 1,350,335 | ||
30-Day Average Volume | 2,576,802 | ||
1-Week Change | 4.08% | ||
1-Month Change | -2.14% | ||
1-Year Change | 148.98% | ||
3-Year Change | 666.81% | ||
5-Year Change | 860.53% | ||
Fundamentals | |||
Shares Outstanding | 142.0M | ||
Total Assets | $179.6M | ||
Market Cap | $2.6B | ||
Enterprise Value | $2.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.2M | ||
Free Cash Flow | -$16.8M | ||
EBIT | -$13.2M | ||
EBITDA | -$13.2M | ||
Net Working Capital | $169.0M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -195 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 15 | ||
P/E | -203 | ||
PEG | 4 | ||
Price/Free Cash Flow | -154 | ||
Price/Operating Cash Flow | -155 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue